Skip to main content
Erschienen in: Clinical Rheumatology 4/2010

01.04.2010 | Case Report

Spondyloarthritis after bariatric surgery: is there a link?

verfasst von: Daniel Sá Ribeiro, João Luiz Fernandes, Leandro Rangel, César de Araújo Neto, Fernando D’Almeida, Carlos Geraldo Moura, Mittermayer B. Santiago

Erschienen in: Clinical Rheumatology | Ausgabe 4/2010

Einloggen, um Zugang zu erhalten

Abstract

Presently, bariatric surgery is considered the most effective treatment for reducing excess body weight and maintaining weight loss in severely obese. On the other hand, several early and late complications have been described after this procedure. This article reports two patients who developed a spondyloarthritis-like syndrome after bariatric surgery. Probable etiopathogenic mechanisms are discussed.
Literatur
1.
Zurück zum Zitat Miller K (2004) Obesity: surgical options. Best Pract Res Clin Gastroenterol 18(6):1147–1165PubMed Miller K (2004) Obesity: surgical options. Best Pract Res Clin Gastroenterol 18(6):1147–1165PubMed
2.
Zurück zum Zitat Sauerland S, Angrisani L, Belachew M, Chevallier JM, Favretti F, Finer N et al (2005) Obesity surgery: evidence-based guidelines of the European Association for Endoscopic Surgery (EAES). Surg Endosc 19(2):200–221CrossRefPubMed Sauerland S, Angrisani L, Belachew M, Chevallier JM, Favretti F, Finer N et al (2005) Obesity surgery: evidence-based guidelines of the European Association for Endoscopic Surgery (EAES). Surg Endosc 19(2):200–221CrossRefPubMed
3.
Zurück zum Zitat Msika S (2003) Surgery for morbid obesity: 2. Complications. Results of a technologic evaluation by the ANAES. J Chir (Paris) 140(1):4–21 Msika S (2003) Surgery for morbid obesity: 2. Complications. Results of a technologic evaluation by the ANAES. J Chir (Paris) 140(1):4–21
4.
Zurück zum Zitat Shikora SA, Kim JJ, Tarnoff ME (2007) Nutrition and gastrointestinal complications of bariatric surgery. Nutr Clin Pract 22(1):29–40CrossRefPubMed Shikora SA, Kim JJ, Tarnoff ME (2007) Nutrition and gastrointestinal complications of bariatric surgery. Nutr Clin Pract 22(1):29–40CrossRefPubMed
5.
Zurück zum Zitat Bell BJ, Bour ES, Scott JD, Cobb WS, Carbonell AM (2009) Management of complications after laparoscopic Roux-en-Y gastric bypass. Minerva Chir 64(3):265–276PubMed Bell BJ, Bour ES, Scott JD, Cobb WS, Carbonell AM (2009) Management of complications after laparoscopic Roux-en-Y gastric bypass. Minerva Chir 64(3):265–276PubMed
6.
Zurück zum Zitat Bernstein CN, Blanchard JF, Rawsthorne P, Yu N (2001) The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol 96(4):1116–1122CrossRefPubMed Bernstein CN, Blanchard JF, Rawsthorne P, Yu N (2001) The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol 96(4):1116–1122CrossRefPubMed
7.
Zurück zum Zitat Bernstein CN (2001) Extraintestinal manifestations of inflammatory bowel disease. Curr Gastroenterol Rep 3(6):477–483CrossRefPubMed Bernstein CN (2001) Extraintestinal manifestations of inflammatory bowel disease. Curr Gastroenterol Rep 3(6):477–483CrossRefPubMed
8.
Zurück zum Zitat Kreisel W, Wolf LM, Grotz W, Grieshaber M (1996) Renal tubular damage: an extraintestinal manifestation of chronic inflammatory bowel disease. Eur J Gastroenterol Hepatol 8(5):461–468PubMed Kreisel W, Wolf LM, Grotz W, Grieshaber M (1996) Renal tubular damage: an extraintestinal manifestation of chronic inflammatory bowel disease. Eur J Gastroenterol Hepatol 8(5):461–468PubMed
9.
Zurück zum Zitat Campbell JM, Hunt TK, Karam JH, Forsham PH (1977) Jejunoileal bypass as a treatment of morbid obesity. Arch Intern Med 137(5):602–610CrossRefPubMed Campbell JM, Hunt TK, Karam JH, Forsham PH (1977) Jejunoileal bypass as a treatment of morbid obesity. Arch Intern Med 137(5):602–610CrossRefPubMed
10.
Zurück zum Zitat Halverson JD, Wise L, Wazna MF, Ballinger WF (1978) Jejunoileal bypass for morbid obesity. A critical appraisal. Am J Med 64(3):461–475CrossRefPubMed Halverson JD, Wise L, Wazna MF, Ballinger WF (1978) Jejunoileal bypass for morbid obesity. A critical appraisal. Am J Med 64(3):461–475CrossRefPubMed
11.
Zurück zum Zitat Scott HW, Law DH, Sandstead HH, Lanier VC, Younger RK (1970) Jejunoileal shunt in surgical treatment of morbid obesity. Arch Surg 171:770–782, Ref Type: Generic Scott HW, Law DH, Sandstead HH, Lanier VC, Younger RK (1970) Jejunoileal shunt in surgical treatment of morbid obesity. Arch Surg 171:770–782, Ref Type: Generic
12.
Zurück zum Zitat Griffen WO Jr, Bivins BA, Bell RM (1983) The decline and fall of the jejunoileal bypass. Surg Gynecol Obstet 157(4):301–308PubMed Griffen WO Jr, Bivins BA, Bell RM (1983) The decline and fall of the jejunoileal bypass. Surg Gynecol Obstet 157(4):301–308PubMed
13.
Zurück zum Zitat Telmos AJ (1977) Long-term morbidity of jejunoileal bypass. Am Surg 43(6):389–391PubMed Telmos AJ (1977) Long-term morbidity of jejunoileal bypass. Am Surg 43(6):389–391PubMed
14.
Zurück zum Zitat Delamere JP, Baddeley RM, Walton KW (1983) Jejuno-ileal bypass arthropathy: its clinical features and associations. Ann Rheum Dis 42(5):553–557CrossRefPubMed Delamere JP, Baddeley RM, Walton KW (1983) Jejuno-ileal bypass arthropathy: its clinical features and associations. Ann Rheum Dis 42(5):553–557CrossRefPubMed
15.
Zurück zum Zitat Clegg DO, Samuelson CO Jr, Williams HJ, Ward JR (1980) Articular complications of jejunoileal bypass surgery. J Rheumatol 7(1):65–70PubMed Clegg DO, Samuelson CO Jr, Williams HJ, Ward JR (1980) Articular complications of jejunoileal bypass surgery. J Rheumatol 7(1):65–70PubMed
16.
Zurück zum Zitat Clegg DO, Zone JJ, Samuelson CO Jr, Ward JR (1985) Circulating immune complexes containing secretory IgA in jejunoileal bypass disease. Ann Rheum Dis 44(4):239–244CrossRefPubMed Clegg DO, Zone JJ, Samuelson CO Jr, Ward JR (1985) Circulating immune complexes containing secretory IgA in jejunoileal bypass disease. Ann Rheum Dis 44(4):239–244CrossRefPubMed
17.
Zurück zum Zitat Fisch C, Schiller P, Harr T, Maclachlan D (2001) First presentation of intestinal bypass syndrome 18 yrs after initial surgery. Rheumatology (Oxford) 40(3):351–353CrossRef Fisch C, Schiller P, Harr T, Maclachlan D (2001) First presentation of intestinal bypass syndrome 18 yrs after initial surgery. Rheumatology (Oxford) 40(3):351–353CrossRef
18.
Zurück zum Zitat Leff RD, Towles W, do-Benson MA, Madura J, Biegel AA (1983) A prospective analysis of the arthritis syndrome and immune function in jejunoileal bypass patients. J Rheumatol 10(4):612–618PubMed Leff RD, Towles W, do-Benson MA, Madura J, Biegel AA (1983) A prospective analysis of the arthritis syndrome and immune function in jejunoileal bypass patients. J Rheumatol 10(4):612–618PubMed
19.
Zurück zum Zitat Heyn J, Hey H, Jans H, Baek L, Ullman S, Halberg P (1983) Episodic arthritis, skin manifestations and immune complexes following intestinal bypass operations for morbid obesity. Scand J Rheumatol 12(3):257–259CrossRefPubMed Heyn J, Hey H, Jans H, Baek L, Ullman S, Halberg P (1983) Episodic arthritis, skin manifestations and immune complexes following intestinal bypass operations for morbid obesity. Scand J Rheumatol 12(3):257–259CrossRefPubMed
20.
Zurück zum Zitat Corrodi P, Wideman PA, Sutter VL, Drenick EJ, Passaro E Jr, Finegold SM (1978) Bacterial flora of the small bowel before and after bypass procedure for morbid obesity. J Infect Dis 137(1):1–6PubMed Corrodi P, Wideman PA, Sutter VL, Drenick EJ, Passaro E Jr, Finegold SM (1978) Bacterial flora of the small bowel before and after bypass procedure for morbid obesity. J Infect Dis 137(1):1–6PubMed
21.
Zurück zum Zitat Corrodi P (1984) Jejunoileal bypass: change in the flora of the small intestine and its clinical impact. Rev Infect Dis 6(Suppl 1):S80–S84PubMed Corrodi P (1984) Jejunoileal bypass: change in the flora of the small intestine and its clinical impact. Rev Infect Dis 6(Suppl 1):S80–S84PubMed
22.
Zurück zum Zitat Fornaciari G, Salvarani C, Beltrami M, Macchioni P, Stockbrugger RW, Russel MG (2001) Muscoloskeletal manifestations in inflammatory bowel disease. Can J Gastroenterol 15(6):399–403PubMed Fornaciari G, Salvarani C, Beltrami M, Macchioni P, Stockbrugger RW, Russel MG (2001) Muscoloskeletal manifestations in inflammatory bowel disease. Can J Gastroenterol 15(6):399–403PubMed
23.
Zurück zum Zitat Mader R, Segol O, Adawi M, Trougoboff P, Nussinson E (2005) Arthritis or vasculitis as presenting symptoms of Crohn's disease. Rheumatol Int 25(6):401–405CrossRefPubMed Mader R, Segol O, Adawi M, Trougoboff P, Nussinson E (2005) Arthritis or vasculitis as presenting symptoms of Crohn's disease. Rheumatol Int 25(6):401–405CrossRefPubMed
24.
Zurück zum Zitat Mody GM, Cassim B (1998) Rheumatologic manifestations of gastrointestinal disorders. Curr Opin Rheumatol 10(1):67–72CrossRefPubMed Mody GM, Cassim B (1998) Rheumatologic manifestations of gastrointestinal disorders. Curr Opin Rheumatol 10(1):67–72CrossRefPubMed
25.
Zurück zum Zitat De VM (2004) Review article: joint involvement in inflammatory bowel disease. Aliment Pharmacol Ther 20(Suppl 4):36–42 De VM (2004) Review article: joint involvement in inflammatory bowel disease. Aliment Pharmacol Ther 20(Suppl 4):36–42
26.
Zurück zum Zitat Veloso FT, Carvalho J, Magro F (1996) Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients. J Clin Gastroenterol 23(1):29–34CrossRefPubMed Veloso FT, Carvalho J, Magro F (1996) Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients. J Clin Gastroenterol 23(1):29–34CrossRefPubMed
Metadaten
Titel
Spondyloarthritis after bariatric surgery: is there a link?
verfasst von
Daniel Sá Ribeiro
João Luiz Fernandes
Leandro Rangel
César de Araújo Neto
Fernando D’Almeida
Carlos Geraldo Moura
Mittermayer B. Santiago
Publikationsdatum
01.04.2010
Verlag
Springer-Verlag
Erschienen in
Clinical Rheumatology / Ausgabe 4/2010
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-009-1351-4

Weitere Artikel der Ausgabe 4/2010

Clinical Rheumatology 4/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Ist Fasten vor Koronarinterventionen wirklich nötig?

Wenn Eingriffe wie eine Koronarangiografie oder eine Koronarangioplastie anstehen, wird häufig empfohlen, in den Stunden zuvor nüchtern zu bleiben. Ein französisches Forscherteam hat diese Maßnahme hinterfragt.

Typ-2-Diabetes: Ernährungsunsicherheit vervierfacht Risiko für schwere Hypoglykämien

04.06.2024 Typ-2-Diabetes Nachrichten

Wenn ältere Menschen mit Typ-2-Diabetes Schwierigkeiten beim Beschaffen und Zubereiten von Mahlzeiten haben, geht dies mit einem deutlich gesteigerten Risiko für schwere Hypoglykämien einher.

Mehr Brustkrebs, aber weniger andere gynäkologische Tumoren mit Levonorgestrel-IUS

04.06.2024 Levonorgestrel Nachrichten

Unter Frauen, die ein Levonorgestrel-freisetzendes intrauterines System (IUS) verwenden, ist die Brustkrebsrate um 13% erhöht. Dafür kommt es deutlich seltener zu Endometrium-, Zervix- und Ovarialkarzinomen.

GLP-1-Agonist Semaglutid wirkt kardio- und nephroprotektiv

03.06.2024 Semaglutid Nachrichten

Der GLP-1-Agonist Semaglutid hat in der FLOW-Studie bewiesen, dass sich damit die Progression chronischer Nierenerkrankungen bei Patienten mit Typ-2-Diabetes bremsen lässt. Auch in kardiovaskulärer Hinsicht war die Therapie erfolgreich.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.